In micro-arrayed compound screening (µARCS), an agarose gel is used as a reaction vessel that maintains humidity and compound location as well as being a handling system for reagent addition. Two or more agarose gels may be used to bring test compounds, targets, and reagents together, relying on the pore size of the gel matrix to regulate diffusion of reactants. It is in the microenvironment of the agarose matrix that all the components of an enzymatic reaction interact and result in inhibitable catalytic activity. In an effort to increase the throughput of µARCS-based screens, reduce the effort involved in manipulating agarose gels, and reduce costs, blotter paper was used rather than a second agarose gel to introduce a substrate to a gel containing a target enzyme. In this assay, the matrix of the blotter paper did not prevent the substrate from diffusing into the enzyme gel. The compound density of the µARCS format, the ease of manipulating sheets of paper for reagent addition, and a scheduled protocol for running multiple gels allowed for a throughput capacity of more than 200,000 tests per hour. A protease assay was developed and run in the µARCS format at a rate of 200,000 tests per hour using blotter paper to introduce the substrate. Picks in the primary screen were retested in the µARCS format at a density of 384 compounds per sheet. IC 50 values were confirmed in a 96-well plate format. The screen identified several small molecule inhibitors of the enzyme. The details of the screening format and the analysis of the hits from the screen are presented. (Journal of Biomolecular Screening 2003: 668-675) 
INTRODUCTION
T HE PRINCIPLE OF MICRO-ARRAYED COMPOUND SCREENING (µARCS) is based ultimately on the Ouchterlony immunodiffusion method for detecting antigen-specific antibodies. 1 Ouchterlony immunodiffusion uses an agar matrix containing paired sets of wells into which are placed antibodies and antigens, respectively. The antibodies and antigens diffuse through the agar and interact, forming discernable zones of immunoprecipitation. Subsequently, the concept of matrix diffusion was applied in the agar disc diffusion assay format to test for antibacterial activity in clinical samples. 2, 3 By placing a sterile paper disc containing an antibiotic on an agar substrate seeded with bacteria, a lawn of bacteria grows, except for a dead zone around the paper disc where the antibiotic has diffused into the agar to prevent bacterial growth. Later, application of the matrix diffusion technique expanded into highthroughput screening (HTS) with gel permeation methods for screening combinatorial peptide libraries. 4, 5 Currently, combinatorial compounds synthesized on polymeric beads are resuspended in an agarose gel containing the target of interest. Cleavage of the chemical compounds from the beads, and subsequent diffusion of the compounds into the gel, permit interactions with the target. 6 Zones of activity are analyzed to identify active combinatorial compounds.
In µARCS, an HTS target is resuspended into a 3-dimensional matrix (typically a 1% agarose gel), and this matrix is brought into contact with 8640 discrete compounds dried onto a polystyrene compound sheet. [7] [8] [9] [10] The compounds diffuse into the matrix and interact with the target. Using a 2nd agarose gel, additional reaction components are brought into contact with the target gel, the reactants diffuse between the gels, and the reaction is initiated. Zones of compound activity can be observed under appropriate imaging conditions. 7-10 A series of dye spots around the perimeter and down the center of the compound sheet provide a constellation that can be used by Abbott's custom HTS software to ultimately locate and identify compounds that demonstrate activity against the target. Currently, the footprint of the compound sheet used in µARCS is similar to that of a 96-well plate because most HTS imaging and plate-reading technologies are based on the 96-well plate format.
The µARCS technology is licensed to and commercially available from Discovery Partners International (San Diego, CA).
A simple protease inhibition assay was adapted to the µARCS format. With the increased compound density of the µARCS platform (8640 compounds per compound sheet), the use of blotter paper to apply substrate, and a scheduled screening protocol, a screening rate of greater than 200,000 tests per hour was achieved. Inhibitors in the primary screen were retested in the µARCS format at a density of 384 compounds per compound sheet. IC 50 values were confirmed in a 96-well plate format. The screen identified a number of small molecule inhibitors of the enzyme. The details of the screening format and the analysis of the hits from the screen are presented.
MATERIAL AND METHODS

Assay reagents
Buffers, agarose, and cell culture reagents were purchased from Invitrogen (Carlsbad, CA). Protease substrate (gly-pro-7-amido-4-methylcoumarin) was purchased from Sigma-Aldrich (St. Louis, MO). Blotter paper (#703) was purchased from VWR (Buffalo Grove, IL). Polystyrene sheets were purchased from Tekra Corp. (New Berlin, WI). Caco-2 cells were obtained from ATCC (Manassas, VA).
Preparation of cell extract containing protease
Caco-2 cells endogenously expressing the protease were cultured and maintained at 37°C with 5% CO 2 in low glucose DMEM supplemented with 10% fetal bovine serum and antibiotic/antimycotic. Cells were seeded at a density to achieve confluence within 7 days. The cells were then cultured for an additional 14 days to allow for maximal protease expression. On the day of harvest, cells were washed once with Dulbecco's phosphate buffered saline (DPBS) and solubilized in 50 mM Tris HCl, pH 8.0, 10 mM NaCl, 0.5% Nonidet P40, 0.3 ug/ml aprotinin. The extract was clarified by centrifugation at 35,000g for 30 min at 4°C.
Compound sheets
During development, test strips of polystyrene sheets were spotted with 1 µl of a known inhibitor at different concentrations and then dried under vacuum. The amount of the compound in the spots ranged from 5 fmol to 3.3 nmol. Compound sheets for primary screening contained 8640 discrete compound spots, with each spot containing 200 pmol of compound. 11 For each set of 8640 discrete compounds, 2 compound sheets were produced, each containing the same 8640 compounds but in a different arrangement to facilitate deconvolution of active compounds. Retest compound sheets were spotted at a density of 384 compounds per sheet (200 pmol each compound). Both primary and retest com-pound sheets contain a series of inert dye spots (constellation) around the sheet perimeter and down the sheet center. The constellation is used by Abbott's custom HTS software to orient and fit the compound sheet to database compound maps and to triangulate the location and identity of compounds picked as active in the assay. 12
Protease assay for primary and retest screening
All reactions were performed at room temperature. Unless otherwise noted, the protease was resuspended in DPBS (Cat# 14190-136; Invitrogen, Carlsbad, CA) to a concentration of 0.012 U/ml and warmed to 37°C. The enzyme solution was then mixed with an equal volume of 2% agarose, 0.2% Triton X-100 in DPBS at 37°C
, and mixed well. The plates of the gel-casting apparatus were precoated with Sigmacote (Sigma, St. Louis, MO). The resulting agarose solution (30 ml) was cast into a 20 cm × 20 cm vertical gel apparatus (Cat# 165-1811; Bio-Rad, Hercules, CA) and cooled for 10 min at 4°C. The gel was removed from the casting apparatus, placed onto a sheet of plastic wrap, and allowed to dry at room temperature for 10 min. The 1% agarose gel was then placed onto polystyrene sheets containing dried compounds. The plastic wrap was removed, and the agarose gel was incubated on the compound sheet for 10 min. During the development of the assay, a second 1% agarose gel containing substrate (substrate gel) was allowed to dry for 10 min at room temperature. After drying, the substrate gel was placed on top of the enzyme gel and incubated for 30 min. At timed intervals during the incubation, the fluorescence at 460 nm was imaged with 360 nm excitation using an Eagle Eye ® II (Stratagene, La Jolla, CA) outfitted with a charge-coupled device (CCD) camera. For the high-throughput screen, the substrate gel was replaced by blotter paper. A 20 cm × 20 cm sheet of blotter paper was soaked with 20 ml of 200 uM substrate, drained briefly, and placed atop the enzyme gel. The blotter paper was removed after 10 min, and the fluorescence at 460 nm was imaged with 360 nm excitation.
Hit picking
Each compound sheet image was loaded into the database and accessed by customized data analysis software developed at Abbott Laboratories. 12 In the format of this assay, active inhibitors of the protease show up as dark spots on a light background. Inhibitors were selected and assigned a subjective "quality" value of 1, 2, or 3, where a quality value of 1 indicated a highly active compound. Compounds that showed activity on both normal and deconvolution sheets were flagged as "matched" compounds in the database. Compounds that showed activity on only 1 of the 2 sheets were flagged as "unmatched" in the database. For all picks, the 8 nearest neighboring compounds were selected for retesting as well as the primary compound. For all quality 1 picks, the 16 next-nearest neighboring compounds were selected for retesting as well.
ARCS Protease Screen
IC 50 assays
All IC 50 determinations were performed in a 96-well plate format. The reaction buffer and enzyme and substrate concentrations were identical to those used in the primary and retesting screens. Reactions contained test compounds in a 1:10 dilution from 100 µM across 6 wells in duplicate plates. The DMSO concentration was 1%. The reactions were incubated at room temperature for 10 min, and the fluorescence at 460 nm determined with 360 nm excitation. Nonspecific activity was determined in the presence of 10 µM of a known selective inhibitor. IC 50 s were determined by nonlinear regression in the customized data analysis software developed at Abbott Laboratories.
Image manipulation and analysis
Image manipulation and pixel analysis was performed using Scion Image (Scion Corp, Frederick, MD).
RESULTS AND DISCUSSION
A time course of the assay was performed to determine the optimal incubation time. The reaction reached half-maximum signal by 15 min and was completed by 60 min (Fig. 1 ). For the first 15 min of the reaction, the apparent reaction rate was approximately linear. A value of 10 min was chosen as a suitable endpoint for the identification of inhibitors and the determination of compound activities. This endpoint was chosen because it provides linear kinetics, a robust signal, and a high signal-to-background ratio. The initial buffer conditions consisted of 140 mM NaCl, 10 mM KCl, 1% bovine serum albumin, 50 mM Tris, pH 7.6. For the ac-tual primary and retest screening, DPBS buffer was substituted without any change in enzyme kinetics or pharmacology (data not shown).
The DMSO tolerance of the enzyme reaction was evaluated. This was necessary because the compound collection that was screened is solubilized in DMSO. The reaction could tolerate up to 1% DMSO without significant (16%) change in the total signal ( Fig. 2 ). In addition, the activity of 2 previously characterized and selective control compounds were evaluated to ensure that the reaction conditions were suitable for IC 50 analysis of HTS picks. Control compounds A and B displayed the expected IC 50 s against this protease ( Fig. 3) .
Transfer of the assay from a 96-well format to a µARCS format was straightforward. Cell lysate containing the protease was resus- pended in a 1% agarose gel with DPBS (enzyme gel), and the enzyme gel was divided into strips. The enzyme gels were air dried for 10 min, then placed on a polystyrene sheet prespotted with varying amounts of control compound A and incubated for 10 min. Strips of 1% agarose gels containing different concentrations of substrate (substrate gels) were applied to the enzyme gels, and images of the gels were obtained under UV light in a gel documentation imaging system. Zones of enzyme inhibition (dark spots) can be observed in the gels as the reaction proceeds (Fig. 4A) . The µARCS format for this assay can detect inhibition of at least 5 fmole of compound A (Fig. 4A ). The observation that enzyme inhibition could be resolved in as low as 5 fmol of inhibitor indicates that little, if any, nonspecific hydrolysis of the substrate is present under the conditions of the assay. This ensured that specific inhibitors of the target would be picked in the screen. The rate of the enzyme reaction was dependent on both the concentration of enzyme and the substrate, as would be expected (Fig. 4A ). To obtain quantitative information from the gel, an area of the gel image devoid of inhibitor was selected for pixel analysis. The mean pixel value for this selected area was determined at each time point of the assay and plotted (Fig. 4B ). The graph of the pixel data recapitulates the image data, confirming that the rate of the enzyme reaction is dependent on the substrate concentration ( Figs. 4A and 4B) . At longer exposure times, the fluorescence from the gels saturated the CCD camera at the settings used, and it was not possible to observe the nonlinear portion of the reaction. It was observed that a sheet of blotter paper could substitute for an agarose gel for applying substrate to a µARCS reaction. 13, 14 For the protease screen, blotter paper was investigated as a means to add the substrate to the enzyme gel. It was observed that blotter paper (substrate paper) could be used to add substrate to the protease reaction in the gel without loss of enzyme activity, although the substrate paper had to be removed prior to imaging to obtain a sharp image of the enzyme gel (Figs. 5A and 5B). It was determined that a 20 cm × 20 cm sheet of blotter paper could be saturated with 20 ml of solution, 33% less than was used in making a comparable sized agarose gel (data not shown). Because a sheet of blotter paper was easier to manipulate and used less reagent than a gel, it was decided to perform the protease screen using blotter paper to add substrate to the reaction.
It was observed that the enzymatic reaction could take place in the matrix of the blotter paper (data not shown). The possibility of substituting agarose gels with paper or other porous matrices for A B some µARCS screens is highly desirable given the relative time and effort of gel preparation. However, due to the fibrous nature of the paper matrix, spot resolution is compromised in images of the substrate paper in this assay. Therefore, images of the enzyme gel were used in the screen rather than images of the substrate paper. Although the substitution of paper or other porous matrix materials for agarose in µARCS appears possible, it is quite likely that specific matrix materials (including agarose) will be optimal for different targets, based on matrix properties and chemistries. Investigations into the use of alternative matrices for µARCS assays are continuing.
Due to the difficulty of manipulating gel-casting equipment, the µARCS format can process 6 to 10 gels a day, depending on the assay protocol. By substituting a sheet of blotter paper for the substrate gel, the amount of work and time devoted to gel preparation and manipulation can be reduced. By following a screening schedule and using blotter paper, it is possible to process 12 enzyme gels an hour during a screen. Briefly, an enzyme gel is removed from its casting stand and is laid onto a sheet of plastic wrap stretched around an acrylic frame. Precoating the gel-casting plates with a silanizing agent and including 0.1% Triton-X100 in the enzyme gel allows the gel to readily slip out from between the glass plates under the force of gravity. The enzyme gel is allowed to dry for 10 min at room temperature and is then applied to 2 compound sheets each containing 8640 compounds. The acrylic frame and plastic wrap are removed, and the compounds are allowed to diffuse into the enzyme gel for 10 min. A substrate paper is then placed on top of the enzyme gel. The substrate paper is removed after 10 min, and the compound sheets and enzyme gel are placed into a gel documentation imaging system. The gel is illuminated with light at 360 nm, and the 460 nm fluorescent emission of the metabolized substrate is captured by a CCD camera. From start to finish, the processing of an enzyme gel takes 30 min to complete. However, it is possible to interleave additional enzyme gels into the schedule such that every 5 min, another gel is initiated. Thus, every 5 min, an enzyme gel is removed from its casting stand for drying, applied to compound sheets, exposed to substrate, and/or imaged according to the schedule outlined in Table 1 . In this manner, 12 enzyme gels can be initiated each hour. The rate of screening achieved is 12 compound sheet sets per hour × 17,280 tests per compound sheet set = 207,360 tests per hour. Even given the initial 30-min lag time, it is possible to screen a million compounds in duplicate in 10 h.
By this method, approximately 800,000 compounds available for the protease target were screened (Figs. 6A-6C ). The Abbott compound library was screened in 3 days as clusters of 10, 20, and 3 compound sheet sets. The Knoll compound library was screened in 1 day as 2 clusters of 15 compound sheet sets. The entire A B C Millenium compound library was screened at one time as a cluster of 21 compound sheet sets. Some images of the compound sheets in the Abbott compound collection contained dark vertical streak marks (Fig. 6A ). The streak marks are a result of applying the substrate solution to a stack of dry blotter sheets prior to use. Subsequent blotter sheets were dipped individually in substrate to avoid this effect. All original compound sheets were prespotted with a control inhibitor at the bottom of the sheet outside the perimeter dye constellation. If a flawed compound sheet was discovered during the screen, it was replaced without prespotting control compounds. Because compound sheets were screened in pairs, at least 1 sheet of a pair had control spots. Although the scheduling ensured that each compound sheet set was treated in the same manner for the same amount of time, varying numbers of active and interfering (e.g., fluorescent) compounds caused image quality to vary from sheet set to sheet set. However, the image collection parame-ters (collection time, f-stop, lamp intensity) could be altered to optimize image resolution and clarity for later picking. The images of each compound sheet were loaded into the database for picking ( Fig. 7A ). Each compound sheet in a set contains the same 8640 compounds but in a different arrangement. As a result, most of the active compounds were the only ones in common between compound clusters surrounding areas of activity found on each compound sheet (Fig. 7B ). Such active compounds were flagged in the database as matched picks. Because of interference (fluorescence, quenching, chemical effects) or a random error in spotting, some compounds showed activity on only a single compound sheet (Fig. 7B) . These compounds were flagged as unmatched in the database. The user has the option of selecting 1, 9, 
A B
matched picks, and an additional 16 next-nearest compounds were selected for retesting from unmatched picks. Compounds picked from the primary screen were retested on compound sheets at a density of 384 compounds per sheet. Because of the lower density, a deconvolution retest compound sheet was not necessary. However, a 2nd identical compound sheet was available and could have been screened to ensure rigorous selection of active compounds for those assays that provide a troublesome protocol or a low signal. Retesting the picks from the primary screen was straightforward due to the high-throughput rate of the µARCS format. Retest sheets showed excellent reproducibility of signal and active compounds ( Figs. 8A and 8B) . Few fluorescent compounds were present on the retest compound sheets, and active compounds clearly stood out from the background signal ( Figs. 8A and 8B) . As with the images from the primary screen, images from the retest compound sheets were loaded into the database for picking.
Compounds picked from the retest compound sheets were received and tested for activity. All IC 50 experiments were performed in a 96-well plate format. All IC 50 determinations were performed at least in duplicate on separate plates for each compound. Activity data were entered into the IC 50 module of the Abbott HTS software for analysis. IC 50 duplicates that differed by greater than a factor of 5 were rejected and retested. Accepted data were automatically registered in the HTS database. A total of 134 compounds displayed activity against the target. The activity of these compounds ranged from 0.3 µM to 100 µM ( Table 2) .
CONCLUSION
A simple protease assay was adapted to the µARCS format and screened at a rate of more than 200,000 tests per hour. This rate was achieved by combining the high-density compound format of µARCS with the use of a screening schedule and blotter paper to add substrate to the reaction. The use of a screening schedule ensured that the assay was reproducible from one compound sheet set to the next. In addition, the use of blotter paper to add substrate to the assay resulted in a 33% decrease in the use of substrate and permitted the increase in screening rate because of its ease of use. Using this format, a collection of a million compounds can be screened in duplicate in 10 h. A range of compound potencies were observed in the µARCS assay and confirmed in a standard 96-well plate format. The observation that the enzymatic reaction could occur unimpeded in the matrix of the blotter paper suggests that the use of agarose can be omitted entirely in some µARCS screens. Although it is unlikely that the use of agarose will be abandoned completely, the use of alternative porous matrices in µARCS promises to simplify the technology and to expand its possible applications. 
